Revelation Biosciences, Inc. (REVB)
NASDAQ: REVB · Real-Time Price · USD
0.9000
-0.0343 (-3.68%)
Sep 24, 2026, 1:47 PM EDT - Market open
Revelation Biosciences Market Cap
Revelation Biosciences has a market cap or net worth of $3.59 million as of September 24, 2026. Its market cap has increased by 43.49% in one year.
Market Cap
3.59M
Enterprise Value
-7.16M
1-Year Change
43.49%
Ranking
Category
Stock Price
$0.90
ChartMarket Cap Chart
Since November 17, 2020, Revelation Biosciences's market cap has decreased from $90.51M to $3.59M, a decrease of -96.04%. That is a compound annual growth rate of -42.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 24, 2026 | 3.59M | -24.34% |
| Dec 31, 2025 | 4.74M | 22.99% |
| Dec 31, 2024 | 3.85M | 22.21% |
| Dec 29, 2023 | 3.15M | -29.09% |
| Dec 30, 2022 | 4.45M | -93.24% |
| Dec 31, 2021 | 65.80M | -29.40% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| 60 Degrees Pharmaceuticals | 4.11M |
| Calidi Biotherapeutics | 4.10M |
| Jupiter Neurosciences | 3.82M |
| Mustang Bio | 3.80M |
| PMGC Holdings | 3.72M |
| GeoVax Labs | 3.48M |
| Addex Therapeutics | 3.44M |
| Aptevo Therapeutics | 3.36M |